VivoSeq
Other

Gastric Intestinal Metaplasia

0

Pipeline Programs↗

3

Active Trials↗

0

Companies Involved↗

Gastric Intestinal Metaplasia is an early-stage landscape with 0 programs across 0 companies.

Intelligence

Pipeline Metrics

Competitive Density

14/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

6

clinical trials

Recruiting2 · 33%
Unknown status2 · 33%
Completed1 · 17%
Not yet recruiting1 · 17%

Clinical Trials

Trial Activity

6 trials

Efficacy and Safety of Ursodeoxycholic Acid in Reversing Gastric Intestinal Metaplasia
Recruiting·—·Phase 4·NCT06610760·196 enrolled
Efficacy and Safety of Weifuchun Tablet in Reversing Gastric Intestinal Metaplasia
Recruiting·—·Phase 4·NCT06610266·400 enrolled
Efficacy and Safety of Berberine for Gastric Intestinal Metaplasia
Not yet recruiting·XXijing Hospital of Digestive Diseases·Phase 4·NCT07129460·204 enrolled
Metformin Efficacy and Safety for Gastric Intestinal Metaplasia
Completed·XXijing Hospital of Digestive Diseases·Phase 4·NCT05288153·140 enrolled
The Efficacy of Severe Whitening and Delayed Fading in Acetic Acid-enhanced Endoscopy for Diagnosing Gastric Intestinal Metaplasia
Unknown status·SShandong University·Phase 1·NCT02806115·100 enrolled
Different Fluorescein Sodium Dosage for the Detection of Gastric Intestinal Metaplasia
Unknown status·SShandong University·Phase 4·NCT02534818·180 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)